Role of activating transcription factor 3 protein ATF3 in necrosis and apoptosis induced by 5-fluoro-2′-deoxyuridine

FEBS Journal

Volumn 281, Issue 7, 2014, Pages 1892-1900

  Sato, Akira ^a,b   Nakama, Kentaro ^a   Watanabe, Hiroki ^a   Satake, Akito ^a   Yamamoto, Akihiro ^a   Omi, Takuya ^a   Hiramoto, Akiko ^a   Masutani, Mitsuko ^b   Wataya, Yusuke ^a   Kim, Hye Sook ^a  

^a OKAYAMA UNIVERSITY   (Japan)

^b NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

Author keywords

activating transcription factor 3 (ATF3); apoptosis; cell death; heat shock protein 90 (HSP90); necrosis

Indexed keywords

ACTIVATING TRANSCRIPTION FACTOR 3; CASPASE 3; FLOXURIDINE; HEAT SHOCK PROTEIN 90; INTERLEUKIN 1BETA CONVERTING ENZYME; MESSENGER RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; ATF3 GENE; CANCER CELL; CELL VIABILITY; CONTROLLED STUDY; DOWN REGULATION; GENE; GENE EXPRESSION; GENE TARGETING; MOUSE; NECROSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROCESSING; UBIQUITINATION; UPREGULATION;

ACTIVATING TRANSCRIPTION FACTOR 3 (ATF3); APOPTOSIS; CELL DEATH; HEAT SHOCK PROTEIN 90 (HSP90); NECROSIS;

ACTIVATING TRANSCRIPTION FACTOR 3; ANIMALS; APOPTOSIS; CELL LINE, TUMOR; FLOXURIDINE; HSP90 HEAT-SHOCK PROTEINS; MICE; NECROSIS; RNA, MESSENGER;

EID: 84897530339     PISSN: 1742464X     EISSN: 17424658     Source Type: Journal    
DOI: 10.1111/febs.12752     Document Type: Article

References (36)

1. Fiers W, Beyaert R, Declercq W, &, Vandenabeele P, (1999) More than one way to die: apoptosis, necrosis and reactive oxygen damage. Oncogene 18, 7719-7730. (Pubitemid 30052757)
2. Denecker G, Vercammen D, Declercq W, &, Vandenabeele P, (2001) Apoptotic and necrotic cell death induced by death domain receptors. Cell Mol Life Sci 58, 356-370. (Pubitemid 32231972)
3. Kakutani T, Ebara Y, Kanja K, Takahashi K, &, Wataya Y, (1998) Different modes of cell death induced by 5-fluoro-2′-deoxyuridine in two clones of the mouse mammary tumor FM3A cell line. Biochem Biophys Res Commun 247, 773-779. (Pubitemid 28418467)
4. Sato A, Hiramoto A, Uchikubo Y, Miyazaki E, Satake A, Naito T, Hiraoka O, Miyake T, Kim HS, &, Wataya Y, (2008) Gene expression profiles of necrosis and apoptosis induced by 5-fluoro-2′-deoxyuridine. Genomics 92, 9-17. (Pubitemid 351842627)
5. Sato A, Hiramoto A, Satake A, Miyazaki E, Naito T, Wataya Y, &, Kim HS, (2008) Association of nuclear membrane protein lamin B1 with necrosis and apoptosis in cell death induced by 5-fluoro-2′-deoxyuridine. Nucleosides Nucleotides Nucleic Acids 27, 433-438. (Pubitemid 351878534)
6. Sato A, Satake A, Hiramoto A, Wataya Y, &, Kim HS, (2010) Protein expression profiles of necrosis and apoptosis induced by 5-fluoro-2′- deoxyuridine in mouse cancer cells. J Proteome Res 9, 2329-2338.
7. Heidelberger C, (1965) Fluorinated pyrimidines. Prog Nucleic Acid Res Mol Biol 4, 1-50.
8. Danenberg PV, (1977) Thymidylate synthetase-a target enzyme in cancer chemotherapy. Biochim Biophys Acta 473, 73-92. (Pubitemid 8238357)
9. Mayer CE, (1980) The pharmacology of the fluoropyrimidines. Pharmacol Rev 33, 1-15.
10. Santi DV, (1980) Perspectives on the design and biochemical pharmacology of inhibitors of thymidylate synthetase. J Med Chem 23, 103-111. (Pubitemid 10219486)
11. Heidelberger C, Danenberg PV, &, Moran RG, (1983) Fluorinated pyrimidines and their nucleosides. Adv Enzymol Relat Areas Mol Biol 54, 58-119.
12. Santi DV, &, Danenberg PV, (1984) Folates in pyrimidine nucleotide biosynthesis. In Folates and Pterins: Volume 1 (, Blakley RL, &, Benkovic SJ, eds), pp. 345-398. John Wiley & Sons, New York.
13. Yoshioka A, Tanaka S, Hiraoka O, Koyama Y, Hirota Y, Ayusawa D, Seno T, Garrett C, &, Wataya Y, (1987) Deoxyribonucleoside triphosphate imbalance. 5-Fluorodeoxyuridine-induced DNA double strand breaks in mouse FM3A cells and the mechanism of cell death. J Biol Chem 262, 8235-8241.
14. Hai T, Wolfgang CD, Marsee DK, Allen AE, &, Sivaprasad U, (1999) ATF3 and stress responses. Gene Expr 7, 321-335. (Pubitemid 29372076)
15. Hai T, &, Hartman MG, (2001) The molecular biology and nomenclature of the activating transcription factor/cAMP responsive element binding family of transcription factors: activating transcription factor proteins and homeostasis. Gene 273, 1-11. (Pubitemid 32718721)
16. Thompson MR, Xu D, &, Williams BR, (2009) ATF3 transcription factor and its emerging roles in immunity and cancer. J Mol Med 87, 1053-1060.
17. Syed V, Mukherjee K, Lyons-Weiler J, Lau KM, Mashima T, Tsuruo T, &, Ho SM, (2005) Identification of ATF-3, caveolin-1, DLC-1, and NM23-H2 as putative antitumorigenic, progesterone-regulated genes for ovarian cancer cells by gene profiling. Oncogene 24, 1774-1787. (Pubitemid 40461133)
18. Mashima T, Udagawa S, &, Tsuruo T, (2001) Involvement of transcriptional repressor ATF3 in acceleration of caspase protease activation during DNA damaging agent-induced apoptosis. J Cell Physiol 188, 352-358. (Pubitemid 32777177)
19. Lu D, Wolfgang CD, &, Hai T, (2006) Activating transcription factor 3, a stress-inducible gene, suppresses Ras-stimulated tumorigenesis. J Biol Chem 281, 10473-10481. (Pubitemid 43864586)
20. Nobori K, Ito H, Tamamori-Adachi M, Adachi S, Ono Y, Kawauchi J, Kitajima S, Marumo F, &, Isobe M, (2002) ATF3 inhibits doxorubicin-induced apoptosis in cardiac myocytes: a novel cardioprotective role of ATF3. J Mol Cell Cardiol 34, 1387-1397. (Pubitemid 35244416)
21. Chen BP, Wolfgang CD, &, Hai T, (1996) Analysis of ATF3, a transcription factor induced by physiological stresses and modulated by gadd153/Chop10. Mol Cell Biol 16, 1157-1168. (Pubitemid 26061687)
22. Allen-Jennings AE, Hartman MG, Kociba GJ, &, Hai T, (2001) The roles of ATF3 in glucose homeostasis. A transgenic mouse model with liver dysfunction and defects in endocrine pancreas. J Biol Chem 276, 29507-29514.
23. Ameri K, Hammond EM, Culmsee C, Raida M, Katschinski DM, Wenger RH, Wagner E, Davis RJ, Hai T, Denko N, et al,. (2007) Induction of activating transcription factor 3 by anoxia is independent of p53 and the hypoxic HIF signalling pathway. Oncogene 26, 284-289. (Pubitemid 46095739)
24. Neckers L, &, Workman P, (2012) Hsp90 molecular chaperone inhibitors: are we there yet? Clin Cancer Res 18, 64-76.
25. da Silva VC, &, Ramos CH, (2012) The network interaction of the human cytosolic 90 kDa heat shock protein Hsp90: a target for cancer therapeutics. J Proteomics 75, 2790-2802.
26. Vanden Berghe T, Kalai M, van Loo G, Declercq W, &, Vandenabeele P, (2003) Disruption of HSP90 function reverts tumor necrosis factor-induced necrosis to apoptosis. J Biol Chem 278, 5622-5629. (Pubitemid 36800804)
27. Lewis J, Devin A, Miller A, Lin Y, Rodriguez Y, Neckers L, &, Liu ZG, (2000) Disruption of hsp90 function results in degradation of the death domain kinase, receptor-interacting protein (RIP), and blockage of tumor necrosis factor-induced nuclear factor-κB activation. J Biol Chem 275, 10519-10526. (Pubitemid 30202115)
28. Kroemer G, Galluzzi L, Vandenabeele P, Abrams J, Alnemri ES, Baehrecke EH, Blagosklonny MV, El-Deiry WS, Golstein P, Green DR, et al,. (2009) Classification of cell death: recommendations of the Nomenclature Committee on Cell Death 2009. Cell Death Differ 16, 3-11.
29. Degterev A, Huang Z, Boyce M, Li Y, Jagtap P, Mizushima N, Cuny GD, Mitchison TJ, Moskowitz MA, &, Yuan J, (2005) Chemical inhibitor of nonapoptotic cell death with therapeutic potential for ischemic brain injury. Nat Chem Biol 1, 112-119.
30. Yamamoto A, Tagawa Y, Yoshimori T, Moriyama Y, Masaki R, &, Tashiro Y, (1998) Bafilomycin A1 prevents maturation of autophagic vacuoles by inhibiting fusion between autophagosomes and lysosomes in rat hepatoma cell line H-4-II-E cells. Cell Struct Funct 23, 33-42. (Pubitemid 28223394)
31. Zong WX, &, Thompson CB, (2006) Necrotic death as a cell fate. Genes Dev 20, 1-15. (Pubitemid 43042662)
32. Chaitanya GV, Steven AJ, &, Babu PP, (2010) PARP-1 cleavage fragments: signatures of cell-death proteases in neurodegeneration. Cell Commun Signal 8, 31.
33. Whitesell L, Mimnaugh EG, De Costa B, Myers CE, &, Neckers LM, (1994) Inhibition of heat shock protein HSP90-pp60v-src heteroprotein complex formation by benzoquinone ansamycins: essential role for stress proteins in oncogenic transformation. Proc Natl Acad Sci USA 91, 8324-8328.
34. Chen BP, Liang G, Whelan J, &, Hai T, (1994) ATF3 and ATF3ΔZip. Transcriptional repression versus activation by alternatively spliced isoforms. J Biol Chem 269, 15819-15826.
35. Yan C, Lu D, Hai T, &, Boyd DD, (2005) Activating transcription factor 3, a stress sensor, activates p53 by blocking its ubiquitination. EMBO J 24, 2425-2435. (Pubitemid 41032593)
36. Mo P, Wang H, Lu H, Boyd DD, &, Yan C, (2010) MDM2 mediates ubiquitination and degradation of activating transcription factor 3. J Biol Chem 285, 26908-26915.